| pubmed-article:2649509 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C0028944 | lld:lifeskim |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C0069428 | lld:lifeskim |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C1417228 | lld:lifeskim |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C1254042 | lld:lifeskim |
| pubmed-article:2649509 | lifeskim:mentions | umls-concept:C0205148 | lld:lifeskim |
| pubmed-article:2649509 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2649509 | pubmed:dateCreated | 1989-5-24 | lld:pubmed |
| pubmed-article:2649509 | pubmed:abstractText | The myelin-oligodendrocyte glycoprotein (MOG) is a minor component of central nervous system myelin. Using neonatal rat optic nerve oligodendrocyte cultures we have compared the development in vitro of MOG with galactocerebroside, myelin basic protein and 2' ,3'-cyclic-nucleotide 3'-phosphodiesterase. MOG appears on the surface of oligodendrocytes 1-2 days later than these other oligodendrocyte markers, suggesting that MOG may be a useful indicator of oligodendrocyte maturation. The relevance of these findings for investigating mechanisms of myelin injury in vitro and the role of oligodendrocyte damage in demyelinating disease is discussed. | lld:pubmed |
| pubmed-article:2649509 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2649509 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2649509 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2649509 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2649509 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2649509 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2649509 | pubmed:month | May | lld:pubmed |
| pubmed-article:2649509 | pubmed:issn | 0165-5728 | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:CampbellA KAK | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:CompstonD ADA | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:MorganB PBP | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:LiningtonCC | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:ScoldingN JNJ | lld:pubmed |
| pubmed-article:2649509 | pubmed:author | pubmed-author:FrithSS | lld:pubmed |
| pubmed-article:2649509 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2649509 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:2649509 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2649509 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2649509 | pubmed:pagination | 169-76 | lld:pubmed |
| pubmed-article:2649509 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:meshHeading | pubmed-meshheading:2649509-... | lld:pubmed |
| pubmed-article:2649509 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2649509 | pubmed:articleTitle | Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. | lld:pubmed |
| pubmed-article:2649509 | pubmed:affiliation | Department of Medicine, University of Wales College of Medicine, Cardiff, U.K. | lld:pubmed |
| pubmed-article:2649509 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2649509 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2649509 | lld:pubmed |
